Similarly, Lige Wu et al. demonstrated that M2-type tumor-associated macrophages (M2-TAMs) may attenuate the antitumor immune response of CD8+ T cells in lung adenocarcinoma (LUAD) through the upregulation of METTL3 in tumor cells. The gene discussed is CD8A; the disease is neoplasm.